InsidersTradesSigma
Green Vision Biotechnology CORP. Stock: price and management transactions · United States · SEC (Form 4)
Follow the Green Vision Biotechnology CORP. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Food & Agriculture sector, Green Vision Biotechnology CORP. has logged 3 insider filings. The latest transaction was reported on 10 February 2022 (Acquisition). Among the most active insiders: LEUNG KWONG TAK. Every trade is free.
3
Insider Decl.
0
Thresholds
€203,354
2 ops.
Buy Volume
€198,956
1 ops.
Sell Volume
31Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 February 2022
Declarations3 total
75,674,200 shares@ US$0.00350.0% of flowCommon StockSEC:0001707195-22-000002:0
Ideal exit: 14 Oct 2022 (T+270)
75,674,200 shares@ US$0.00348.9% of flowCommon StockSEC:0001707066-22-000001:0
1,784,200 shares@ US$0.0031.1% of flowCommon StockSEC:0001707066-21-000001:0
Ideal exit: 22 Nov 2021 (T+270)
3 of 3 declarations
About Green Vision Biotechnology CORP.
GREEN VISION BIOTECHNOLOGY CORP. is a United States-incorporated company with a long and complex corporate history, best understood today as a small-cap, high-risk issuer with an agricultural and green-products orientation rather than a traditional large biotechnology platform. The company was incorporated in Nevada on July 5, 2012, originally under the name Any Translation Corp., and its early business focus was translation and interpretation services. It later changed its name to Vibe Wireless Corp. and then to Green Vision Biotechnology Corp. in 2016, reflecting a strategic repositioning toward environmentally oriented products and agricultural applications. According to SEC materials, GVBT describes itself as a pioneer in the research and development of green products, particularly bio-fertilizers for the agricultural sector in the People’s Republic of China, and it has also stated an intention to expand into trading agricultural products, cold storage, and related logistics activities. The company’s business address has been referenced in Hong Kong, underscoring that although it is legally organized in the United States, its operational footprint has been largely Asia-facing. From a competitive standpoint, GVBT appears to operate in a niche segment where scale, distribution access, and execution matter more than brand recognition. It does not appear to have the profile of a major NYSE or NASDAQ growth name; rather, it has the characteristics of a thinly followed micro-cap with a limited public information footprint. One of the most important recent developments is that the company announced in 2022 that it would voluntarily file Form 15 to suspend its SEC reporting obligations, citing a desire to reduce compliance costs and preserve resources for business operations and potential corporate transactions. That move materially reduces transparency versus fully reporting U.S.-listed peers. For investors, the key takeaways are the company’s incorporation in the United States, its evolving business model centered on agricultural bio-products and logistics, its Hong Kong-linked operating structure, and its recent emphasis on cost reduction and strategic flexibility. In short, GREEN VISION BIOTECHNOLOGY CORP. should be viewed as a small, restructuring-oriented agricultural biotech story with limited disclosure, not as a mainstream listed biotech company on NYSE or NASDAQ.
